Related Experiment Video
Updated: Feb 8, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging
Argonde C van Harten1, Michelle M Mielke2, Dana M Swenson-Dravis2
1From the Alzheimer Center (A.C.v.H.), VU University Medical Center, Amsterdam, the Netherlands; Behavioral Neurology, Department of Neurology (A.C.v.H., D.S.K., R.C.P.), Division of Epidemiology, Department of Health Sciences Research (M.M.M., C.E.H., K.K.E., R.O.R., Y.E.G.), and Department of Neurology (M.M.M., D.M.S.-D.), Mayo Clinic, Rochester, MN; Mayo Clinic Translational Neuroscience and Aging Program (Y.E.G.), and Departments of Psychiatry and Psychology (Y.E.G.) and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ. a.vanharten@vumc.nl.
Objective:
We investigated different dimensions of subjective cognitive decline (SCD) to determine which was the best prognostic risk factor for incident mild cognitive impairment (MCI) among cognitively unimpaired participants.
Methods:
We included 1,167 cognitively unimpaired participants, aged 70 to 95 years, from the Mayo Clinic Study of Aging based on 2 concurrent SCD scales (part of the Blessed memory test and the 39-item Everyday Cognition [ECog] scale, which included a validated 12-item derivative) and a single question assessing worry about cognitive decline. We evaluated multiple ways to dichotomize scores. In continuous models, we compared average scores on 4 ECog domains and multidomain (39- and 12-item) ECog scores. Cox proportional hazards models were used to assess the association between each measure and risk of MCI in models adjusted for objective memory performance, depression, anxiety, sex, APOE ε4 carriership, and medical comorbidities.
Results:
It was possible to select a substantial group of participants (14%) at increased risk of incident MCI based on combined baseline endorsement of any consistent SCD on the ECog (any item scored ≥3; 12-item ECog hazard ratio [HR] 2.17 [95% confidence interval 1.51-3.13]) and worry (HR 1.79 [1.24-2.58]) in an adjusted model combining these dimensions. In continuous models, all ECog domains and the multidomain scores were associated with risk of MCI with a small advantage for multidomain SCD (12-item ECog HR 2.13 [1.36-3.35] per point increase in average score). Information provided by the informant performed comparable to self-perceived SCD.
Conclusion:
Prognostic value of SCD for incident MCI improves when both consistency of SCD and associated worry are evaluated.
Related Concept Videos
Cognitive Dissonance
Magnetic Declination
Bioavailability Study Design: Healthy Subjects Versus Patients
Conservation of Declining Populations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Relative Risk

